-
Living With Chronic Blood CancerThanks to medical advances, more people with blood cancer are living for years or even decades after their diagnosis. But when these diseases are incurable, patients must learn to adjust to ongoing monitoring and treatment.
by Kendall K. Morgan
-
Facts and Stats
Will We Make the Moonshot?As the Cancer Moonshot aims to cut cancer deaths in half by 2047, researchers identify strategies to hit that benchmark.
by Thomas Celona
-
Drop in Cancer Diagnoses Under COVID-19 Raises AlarmsResults of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
by Kyle Bagenstose
-
Choosing Between Lung Cancer Surgery and RadiationStudy suggests surgery leads to longer survival than radiation for non-small cell lung cancer, but radiation remains an important option.
by Jon Kelvey
-
Understanding Disparities in Melanoma DiagnosisBlack men with melanoma are more likely than other populations to die of the disease. Here’s why, and what to look for.
by Kyle Bagenstose
-
After Colorectal Cancer, Survivors Face Higher Risk for a Second CancerResearchers find increased risk of four types of secondary cancer in patients diagnosed with early-onset colorectal cancer.
by Sandra Gordon
-
Sunscreen Is Just the StartExperts say protection against UV rays and watching for changes in your skin are important tools in skin cancer risk prevention.
by Kyle Bagenstose
-
From the Editor-in-Chief
Artificial IntelligenceAI has significant implications for medicine, especially for precision cancer care.
by William G. Nelson, MD, PhD
-
Ovarian Cancer: A Quest to Extend RemissionsNew treatments aim to lengthen remissions and push back recurrences.
by Erin O’Donnell
-
ADCs Make Their MarkAntibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.
by Kendall K. Morgan
After a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
Celebrity Cancer Stories Can Lack Important InformationNews coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.
by Laura Gesualdi Gilmore
AACR Annual Meeting 2025Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
